Yaqrit Limited is a UK-based company specialising in interventions in liver disease based on 20 years of research and development at UCL.
Business Model:
Revenue: $0
Employees: 1-10
Address: Chalk Farm Road
City: Greater London
State: england
Zip: NW1 8AB
Country: GB
Liver cirrhosis kills more than a million people a year. More than 650 million people around the world suffer from chronic liver disease, costing economies €15.8 billion annually. Yaqrit Limited is developing a family of liver disease treatments that will transform the lives of these patients. Today, there are few options for treatment. Antibiotics and laxatives, which target gut bacteria and bacterial products, or a liver transplant are the standards of care. The drawbacks of widespread antibiotic use are well-known, and waiting lists for transplants are long – in the UK, for example, 30% of patients on the waiting list have been there for more than two years.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 9/2020 | Convertible Note | 1 | - |
Trend Investment Group Trend Investment Group |
7/2020 | Private Equity Round | 1 | - |
Riveria Investment Group Riveria Investment Group |
12/2016 | Angel Round | $1.8M | 12/2016 | Grant | 1 | $6.8M |
Horizon 2020 Horizon 2020 |
4/2015 | Grant | 1 | $6.3M |
Horizon 2020 Horizon 2020 |
12/2015 | Angel Round | 1 | $3M |
UCLB UCLB |
9/2020 | Convertible Note | 1 | - |
Trend Investment Group Trend Investment Group |
7/2020 | Private Equity Round | 1 | - |
Riveria Investment Group Riveria Investment Group |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|